Stay updated on Edwards Lifesciences Press Releases

Sign up to get notified when there's something new on the Edwards Lifesciences Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Edwards Lifesciences Press Releases page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    102 days ago
    Change Detected
    Summary
    The webpage has been updated with significant new information regarding Edwards Lifesciences, including upcoming earnings conference calls, recent sales, and clinical trial results, which highlight advancements in their medical technologies and products.
    Difference
    100%
    Check dated 2025-03-11T04:24:22.000Z thumbnail image
  6. Check
    203 days ago
    Change Detected
    Summary
    The latest update highlights the promising real-world outcomes of the Edwards’ SAPIEN 3 Ultra RESILIA Valve as of November 25, 2024, while previous announcements regarding the earnings conference call have been removed.
    Difference
    100%
    Check dated 2024-11-30T13:08:33.000Z thumbnail image
  7. Check
    232 days ago
    Change Detected
    Summary
    Recent updates highlight significant advancements in heart treatment, including the TRISCEND II trial showcasing the benefits of the EVOQUE system for tricuspid regurgitation and new data on EARLY TAVR for asymptomatic aortic stenosis patients.
    Difference
    100%
    Check dated 2024-11-01T10:45:54.000Z thumbnail image
  8. Check
    239 days ago
    Change Detected
    Summary
    Edwards Lifesciences has reported its third quarter results for 2024, while the previous announcement regarding the expansion of its structural heart portfolio through acquisitions has been removed.
    Difference
    100%
    Check dated 2024-10-25T00:41:39.000Z thumbnail image
  9. Check
    246 days ago
    Change Detected
    Summary
    Edwards Lifesciences has announced an upcoming earnings conference call on October 24, 2024, while the previous report on second quarter results from July 24, 2024, has been removed.
    Difference
    100%
    Check dated 2024-10-17T19:14:23.000Z thumbnail image
  10. Check
    290 days ago
    Change Detected
    Summary
    Edwards Lifesciences has completed the sale of its Critical Care division and reported excellent outcomes from the first all-female TAVI trial, while the Careers section and an upcoming earnings conference call have been removed.
    Difference
    100%
    Check dated 2024-09-04T04:59:12.000Z thumbnail image

Stay in the know with updates to Edwards Lifesciences Press Releases

Enter your email address, and we'll notify you when there's something new on the Edwards Lifesciences Press Releases page.